[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

C Tschöpe, E Ammirati, B Bozkurt… - Nature Reviews …, 2021 - nature.com
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

Viral myocarditis—diagnosis, treatment options, and current controversies

A Pollack, AR Kontorovich, V Fuster… - Nature Reviews …, 2015 - nature.com
Myocarditis—a frequent cause of dilated cardiomyopathy and sudden cardiac death—
typically results from cardiotropic viral infection followed by active inflammatory destruction …

Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection

A Sharma, G Garcia, Y Wang, JT Plummer… - Cell Reports …, 2020 - cell.com
Summary Coronavirus disease 2019 (COVID-19) is a pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is defined by respiratory …

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

A Sharma, PW Burridge, WL McKeithan… - Science translational …, 2017 - science.org
Tyrosine kinase inhibitors (TKIs), despite their efficacy as anticancer therapeutics, are
associated with cardiovascular side effects ranging from induced arrhythmias to heart …

RNA–protein interaction detection in living cells

M Ramanathan, K Majzoub, DS Rao, PH Neela… - Nature …, 2018 - nature.com
RNA–protein interactions play numerous roles in cellular function and disease. Here we
describe RNA–protein interaction detection (RaPID), which uses proximity-dependent …

Induced pluripotent stem cells 10 years later: for cardiac applications

Y Yoshida, S Yamanaka - Circulation research, 2017 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) are reprogrammed cells that have features similar to
embryonic stem cells, such as the capacity of self-renewal and differentiation into many …

[HTML][HTML] Cardiovascular disease models: a game changing paradigm in drug discovery and screening

H Savoji, MH Mohammadi, N Rafatian, MK Toroghi… - Biomaterials, 2019 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Although investment in
drug discovery and development has been sky-rocketing, the number of approved drugs has …

[HTML][HTML] Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform

C Denning, V Borgdorff, J Crutchley, KSA Firth… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Cardiomyocytes from human pluripotent stem cells (hPSCs-CMs) could revolutionise
biomedicine. Global burden of heart failure will soon reach USD $90 bn, while unexpected …

Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine

N Sayed, C Liu, JC Wu - Journal of the American College of Cardiology, 2016 - jacc.org
The prospect of changing the plasticity of terminally differentiated cells toward pluripotency
has completely altered the outlook for biomedical research. Human-induced pluripotent …

Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association

K Musunuru, F Sheikh, RM Gupta… - Circulation: Genomic …, 2018 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) offer an unprece-dented opportunity to study human
physiology and disease at the cellular level. They also have the potential to be leveraged in …